Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/3/14  and contains information from public web pages and contributions from the ZoomInfo community.

Sandra A. Milligan

Wrong Sandra A. Milligan?

Board Member

Phone: (215) ***-****  HQ Phone
Drug Information Association
800 Enterprise Road Suite 200
Horsham, Pennsylvania 19044
United States

Company Description: About the Drug Information Association (DIA) The Drug Information Association serves more than 25,000 professionals in the biotechnology, pharmaceutical and...   more
Background

Employment History

  • Vice President, Regulatory Affairs and Therapeutic Area Head, Inflammation
    Genentech , Inc.
  • MD JD and Genentech and Global Therapeutic Area Head, Regulatory Affairs
    Genentech , Inc.
  • Executive Director, Global Regulatory Affairs, Therapeutic Area Head, Bone Oncology
    Amgen Inc
  • Senior Counsel
    Amgen Inc
  • Head of Regulatory Communications Strategy and Operations
    Amgen Inc

Education

  • JD
  • MD
  • The George Washington University School of Medicine and Health Sciences
20 Total References
Web References
DIA | Biography
www.diacert.org, 3 Mar 2014 [cached]
Sandra A Milligan, JD,MD DIA | Biography
...
Sandra A Milligan, JD,MD
...
Sandra Milligan, MD, JD, currently serves as Vice President, Global Regulatory Affairs, Therapeutic Area Head for Inflammation, Infectious Disease and Ophthalmology for Genentech/Roche where she develops and directs global strategic regulatory plans to facilitate and optimize product development, regulatory approval, and commercialization. She previously served at Amgen for 10 years in various roles, including Global Regulatory Therapeutic Area Head for the Bone franchise, as Head of Regulatory Communications Strategy & Operations, and as Senior Counsel, for the Development, Regulatory & Compliance Law Group, where she provided legal strategy for development, regulatory and safety groups. In addition to serving on the DIA Board of Directors, Sandra has served as the Chair of the 2013 DIA Annual Meeting (Boston), as DIA Annual Meeting session chair and as co-chair of the Public Policy/Health Care Compliance/Regulatory Law Annual Meeting track. Sandra is a graduate of The George Washington University School of Medicine and Health Sciences, and of the Georgetown University Law Center.
Sandra A Milligan, ...
www.diaeurope.org, 28 April 2012 [cached]
Sandra A Milligan, JD,MD DIA | Biography
...
Sandra A Milligan, JD,MD
...
Sandra Milligan, MD, JD, currently serves as Executive Director, Global Regulatory Affairs, Therapeutic Area Head, Bone Oncology, for Amgen, where she develops and directs global strategic regulatory plans to facilitate and optimize product development, regulatory approval, and commercialization. She previously served Amgen for five years as Head of Regulatory Communications Strategy & Operations and as Senior Counsel, Development, Regulatory & Compliance Law Group, where she provided strategy for development, regulatory and safety groups. In addition to serving on the DIA Board of Directors, Sandra has served as a DIA Annual Meeting session chair and as co-chair of the Public Policy/Health Care Compliance Annual Meeting track. She has also served on the Program Committee for the annual DIA Marketing of Pharmaceuticals workshop.
Sandra also serves as a Biologics Industry Representative of the FDA Risk Communication Advisory Committee and as member of both the Food & Drug Law Institute (FDLI) Strategic Planning Committee and the FDLI Drugs & Biologic Committee. She is a graduate of The George Washington University School of Medicine and Health Sciences, and of the Georgetown University Law Center.
DIA Announces 2011-2012 Board of Directors
www.diacert.org, 3 Mar 2014 [cached]
Dr. Sandra Milligan, Amgen, USA
DIA | Board of Directors
www.diacert.org, 3 Mar 2014 [cached]
Sandra A Milligan, JD,MD
DIA | Biography
www.diainfo.org, 25 Dec 2013 [cached]
Sandra A Milligan, JD,MD DIA | Biography
...
Sandra A Milligan, JD,MD
...
Sandra Milligan, MD, JD, currently serves as Vice President Global Regulatory Therapeutic Area Head for Inflammation, Virology and Ophthalmology for Genentech Inc., a Member of the Roche Group, where she develops and directs global strategic regulatory plans to facilitate and optimize product development, regulatory approval, and commercialization. She previously served at Amgen for almost 10 years in various roles, including Global Regulatory Therapeutic Area Head for the Bone franchise, as Head of Regulatory Communications Strategy & Operations, and as Senior Counsel, for the Development, Regulatory & Compliance Law Group, where she provided strategy for development, regulatory and safety groups. In addition to serving on the DIA Board of Directors, Sandra has served as a DIA Annual Meeting session chair and as co-chair of the Public Policy/Health Care Compliance/Regulatory Law Annual Meeting track. She is the 2013 Annual Meeting Program Chair. Sandra is a graduate of The George Washington University School of Medicine and Health Sciences, and of the Georgetown University Law Center.
Other People with the name "Milligan":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304